Works matching IS 22351795 AND DT 2023 AND VI 12 AND IP 6

Results: 11

Front & Back Matter.

Published in:: Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 1, doi. 10.1159/000535679
Publication type:: Article

Contents.

Published in:: Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 605, doi. 10.1159/000535164
Publication type:: Article

Acknowledgment to Reviewers.

Published in:: Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 603, doi. 10.1159/000534661
Publication type:: Article

Current Therapeutic Strategies for Hepatocellular Carcinoma in Japan.

Published in:

2023

By:

Kudo, Masatoshi

Publication type:

Editorial

Atezolizumab in Combination with Bevacizumab for the Management of Patients with Hepatocellular Carcinoma in the First-Line Setting: Systematic Literature Review and Meta-Analysis.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 510, doi. 10.1159/000533166

By:

Vogel, Arndt;
Finn, Richard S.;
Blanchet Zumofen, Marie-Hélène;
Heuser, Carolina;
Sanchez Alvarez, Javier;
Leibfried, Michael;
Mitchell, Catherine R.;
Batson, Sarah;
Redhead, Gabrielle;
Gaillard, Vincent E.;
Kudo, Masatoshi

Publication type:

Article

Real-Time Fluorescence Imaging to Identify Cholangiocarcinoma in the Extrahepatic Biliary Tree Using an Enzyme-Activatable Probe.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 590, doi. 10.1159/000530645

By:

Takahashi, Ryugen;
Ishizawa, Takeaki;
Inagaki, Yoshinori;
Tanaka, Mariko;
Ogasawara, Akira;
Kuriki, Yugo;
Fujita, Kyohhei;
Kamiya, Mako;
Ushiku, Tetsuo;
Urano, Yasuteru;
Hasegawa, Kiyoshi

Publication type:

Article

Transcatheter Arterial Chemoembolization for Treatment-Naive Hepatocellular Carcinoma Has Different Treatment Effects Depending on Central or Peripheral Tumor Location.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 576, doi. 10.1159/000530441

By:

Asano, Kazuo;
Kageyama, Ken;
Yamamoto, Akira;
Jogo, Atsushi;
Uchida-Kobayashi, Sawako;
Sohgawa, Etsuji;
Murai, Kazuki;
Kawada, Norifumi;
Miki, Yukio

Publication type:

Article

Attempt to Establish Prognostic Predictive System for Hepatocellular Carcinoma Using Artificial Intelligence for Assistance with Selection of Treatment Modality.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 565, doi. 10.1159/000530078

By:

Hiraoka, Atsushi;
Kumada, Takashi;
Tada, Toshifumi;
Toyoda, Hidenori;
Kariyama, Kazuya;
Hatanaka, Takeshi;
Kakizaki, Satoru;
Naganuma, Atsushi;
Itobayashi, Ei;
Tsuji, Kunihiko;
Ishikawa, Toru;
Ohama, Hideko;
Tada, Fujimasa;
Nouso, Kazuhiro

Publication type:

Article

Computed Tomography-Defined Sarcopenia in Outcomes of Patients with Unresectable Hepatocellular Carcinoma Undergoing Radioembolization: Assessment with Total Abdominal, Psoas, and Paraspinal Muscles.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 550, doi. 10.1159/000529676

By:

Wu, Chih-Horng;
Ho, Ming-Chih;
Chen, Chien-Hung;
Liang, Ja-Der;
Huang, Kai-Wen;
Cheng, Mei-Fang;
Chang, Chih-Kai;
Chang, Chia-Hung;
Liang, Po-Chin

Publication type:

Article

Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 539, doi. 10.1159/000529143

By:

Huang, Chian-Tzu;
Chu, Yu-Long;
Su, Tung-Hung;
Huang, Shang-Chin;
Tseng, Tai-Chung;
Hsu, Shih-Jer;
Liao, Sih-Han;
Hong, Chun-Ming;
Liu, Chen-Hua;
Yang, Hung-Chih;
Liu, Chun-Jen;
Chen, Pei-Jer;
Kao, Jia-Horng

Publication type:

Article

Adverse Events of Immune Checkpoint Inhibitor-Based Therapies for Unresectable Hepatocellular Carcinoma in Prospective Clinical Trials: A Systematic Review and Meta-Analysis.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 6, p. 521, doi. 10.1159/000528698

By:

Zhang, Yizhou;
Wang, Minghao;
Chen, Qichen;
Deng, Yiqiao;
Chen, Jinghua;
Dai, Yimin;
Luo, Sheng;
Xu, Jianming;
Zhao, Hong;
Cai, Jianqiang

Publication type:

Article